LONDON--(BUSINESS WIRE)--Plexāā, a MedTech startup behind the award-winning BLOOM 43 medical device for breast surgery, has announced the close of a $4.5 million funding extension round. The strategic ...
Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free While pET can be an alternative to ...
For the first time in Canada, the country’s leading breast cancer experts have come together to establish national standards ...
Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced that a study just published online in the Journal of Breast Imaging showed ...
Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen treatment burdens. One new study, published in the New England Journal of ...
SAN ANTONIO — A comprehensive patient-level meta-analysis of three randomized trials demonstrated that compared with surgery deferral, immediate breast surgery significantly reduces both local ...